线粒体功能障碍和亡是alpha-B-crystallin desmin相关心肌病的致病过程的基础
Alina Maloyan1, Atsushi Sanbe, Hanna Osinska
1Division of Molecular Cardiovascular Biology, Cincinnati Children's Hospital, Cincinnati, Ohio, USA.
Circulation
|December 1, 2005
概括
突变的alpha-B-crystallin (CryAB) 通过破坏线粒体-sarcomere结构,导致与desmin相关的心肌病. 这会导致心力衰竭,通过线粒体功能受损和亡.
科学领域:
- 心血管生物学 心血管生物学
- 线粒体生物学 线粒体生物学
- 蛋白质病变是一种蛋白质病变.
背景情况:
- 线粒体和瘤保持着一个关键的建筑关系,依赖于细胞骨架.
- 在alpha-B-crystallin (CryAB) 中的一种特定突变 (R120G) 导致与desmin相关的心肌病,由CryAB和desmin的粉素阳性聚合物标记.
- 这种疾病可以通过突变CryAB.的心脏特异性表达在小鼠中进行建模.
研究的目的:
- 研究R120G CryAB表达对心肌细胞结构和功能的直接影响.
- 为了阐明导致心力衰竭的事件序列在与desmin相关的心肌病.
主要方法:
- 在体外研究中,使用R120G CryAB.使用腺病毒介导成年心肌细胞的传染.
- 在转基因小鼠的体内研究中,R120G CryAB.具有心脏特异性表达.
- 对收缩力学,细胞骨完整性,线粒体组织,氧气消耗和亡途径的评估.
主要成果:
- 在体外,R120G表达改变了心肌细胞收缩机制.
- 在体内,早期的细胞骨干扰在器官功能障碍之前,观察到线粒体结构变化.
- 线粒体功能障碍包括减少复杂的I链呼吸,改变透性过渡孔,减少内膜潜力,随后是亡和心力衰竭.
结论:
- 心脏陪伴器功能障碍,以R120G CryAB为例,急性损害心肌细胞机制和线粒体-sarcomere架构.
- 这些干扰导致线粒体功能障碍,亡激活,最终导致心力衰竭.
相关概念视频
01:26Cross-bridge Cycle
As muscle contracts, the overlap between the thin and thick filaments increases, decreasing the length of the sarcomere—the contractile unit of the muscle—using energy in the form of ATP. At the molecular level, this is a cyclic, multistep process that involves binding and hydrolysis of ATP, and movement of actin by myosin.
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
01:28Diabetic Nephropathy
Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:22Myasthenia Gravis ll: Pathophysiology
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...